血必净注射液治疗早期重症急性胰腺炎的临床疗效观察

摘要

目的：观察血必净注射液治疗早期重症急性胰腺炎(SAP)的临床疗效。方法：收治ICU病房SAP患者28例，分为对照组和治疗组各14例，对照组给予常规治疗，治疗组给予在对照组的基础上给予7 d 血必净注射液100 mL，2次/d。对比两组患者的死亡率、ICU住院天数、APACHE Ⅱ评分和实验室指标PCT、CRP等。结果：与对照组相比，观察组的死亡率降低，平均ICU住院天数降低，APACHE Ⅱ评分及PCT、CRP等指标也明显降低。结论：血必净注射液在治疗早期SAP方面表现出有效的治疗效果。%Objective:To observe the clinical curative effect of Xuebijing injection in the treatment of early severe acute pancreatitis(SAP).Methods:28 SAP patients in ICU ward were selected.They were divided into the control group and the treatment group with 14 cases in each.The control group was given conventional treatment.The treatment group was given Xuebijing injection 100 mL on the basis of the control group for 7 days,2 times one days.The mortality,hospitalization time,APACHE Ⅱscore and laboratory indexes of PCT,CRP were compared between groups.Results:Compared with the control group,the mortality of the observation group was reduced;the average ICU hospitalization time was reduced;the APACHE II score and PCT,CRP and other indicators were also significantly reduced.Conclusion:Xuebijing injection in the treatment of early severe acute pancreatitis shows the effective treatment effect.